ClinicalTrialsFinder

Peripheral T-Cell Lymphoma Refractory Clinical Trials in Suzhou

1 recruitingSuzhou, China

Showing 1–1 of 1 trials

Recruiting
Early Phase 1

An Open-label, Single-arm, Multicenter Phase II Clinical Study of Azacitidine, Chidamide Combined With PD-1 Monoclonal Antibody in the Treatment of Refractory/Relapsed Peripheral T-cell Lymphoma.

Peripheral T-Cell Lymphoma Refractory
Second Affiliated Hospital of Soochow University30 enrolled1 locationNCT07598578